G Square has agreed to acquire a majority stake in Serres, a leader in sustainable surgical fluid management, to enhance its global expansion and innovation capabilities.
Information on the Target
Serres, a family-owned company based in Kauhajoki, Finland, has established itself as a global leader in surgical fluid management solutions over the past five decades. Renowned for its high-performance suction bags and fluid disposal systems, Serres plays a critical role in over 80,000 surgical procedures daily and is trusted by 50% of the world's top 100 hospitals. The company has invested in state-of-the-art production facilities in Kauhajoki and Saarijärvi, recognized for their advanced automation capabilities. Long before sustainability became a focal point in healthcare, Serres prioritized circularity and efficiency in its product offerings and operational practices.
The commitment to sustainability is pivotal to Serres' identity. The company emphasizes that sustainability is not merely an addition but the cornerstone of its strategic approach. This guiding principle positions Serres to meet the growing global demand for sustainable single-use solutions, contributing to its robust market position.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Finland
Finland's healthcare sector is characterized by a strong emphasis on sustainability and innovation, reflecting a broader trend toward environmentally responsible healthcare practices. The country's healthcare landscape is supported by advanced technology
Similar Deals
Verso Capital, Armada Credit Partners → Suomen Avustajapalvelut
2025
CapMan Special Situations → Nonna Group Oy, Aurahovi Oy
2025
Evolver Fund II → Repolar Pharmaceuticals Oy
2024
Fysios Mehiläinen → Neurofysio and Bodymind
2024
LähiTapiola Yhteiskuntakiinteistöt Suomi Ky → Espoon Sairaala
2022
G Square
invested in
Serres
in 2026
in a Other Private Equity deal